UPDATE: Dendreon (DNDN) Surges On Request For Congressional Hearing on FDA Provenge Review

December 13, 2007 1:06 PM EST Send to a Friend
Shares of Dendreon (Nasdaq: DNDN) have surged mid-day on reports three Congressmen have requested a hearing be held to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login